Concepedia

Jennifer L. R. Freeman

JL

Statistics

Publications

2

Citations

118

H-Index

2

Active since

2019

Affiliations

vTv Therapeutics (United States)(Current)

University of North Carolina at Chapel Hill

Jennifer L. R. Freeman is an author at vTv Therapeutics (United States) specializing in glycemic control, diabetes management, and medicine.

Publications per year

2019–2021

2

Publications

2

Targeting hepatic glucokinase to treat diabetes with TTP399, a hepatoselective glucokinase activator

Adrian Vella, Jennifer L. R. Freeman, Imogene Dunn et al. · Science Translational Medicine · 2019 · 78 citations

, , +15

The SimpliciT1 Study: A Randomized, Double-Blind, Placebo-Controlled Phase 1b/2 Adaptive Study of TTP399, a Hepatoselective Glucokinase Activator, for Adjunctive Treatment of Type 1 Diabetes

Klara R. Klein, Jennifer L. R. Freeman, Imogene Dunn et al. · Diabetes Care · 2021 · 40 citations · Full text

, , +17

1–2 of 2